Trials / Completed
CompletedNCT02795351
Induction of Migraine Aura With Sildenafil
The Effect of the Selective PDE5 Inhibitor, Sildenafil, on Aura and Migraine Headache Induction.
- Status
- Completed
- Phase
- EARLY_Phase 1
- Study type
- Interventional
- Enrollment
- 16 (actual)
- Sponsor
- Herlev Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Not accepted
Summary
In a double blind placebo-controlled cross-over study the effect of Sildenafil on aura and migraine headache induction is tested in patient with migraine with aura.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Sildenafil | Single oral administration of active or placebo one week apart |
| DRUG | Placebo |
Timeline
- Start date
- 2015-06-01
- Primary completion
- 2021-02-01
- Completion
- 2021-08-01
- First posted
- 2016-06-10
- Last updated
- 2021-11-16
Locations
1 site across 1 country: Denmark
Source: ClinicalTrials.gov record NCT02795351. Inclusion in this directory is not an endorsement.